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Abstract
Our knowledge of how circadian and homeostatic brain circuits interact to temporally organize physiology and behavior is limited.
Progress has been made with the determination that lateral hypothalamic orexin (OXA) neurons control arousal and appetitive
states, while suprachiasmatic nuclei (SCN) neurons function as the master circadian clock. During the day, SCN neurons exhibit
heterogeneity in spontaneous resting membrane potential (RMP), with some neurons becoming severely depolarized (hyperex-
cited) and ceasing to fire action potentials (APs), while other neurons rest at moderate RMP and fire APs. Intriguingly, the day
phase is when the SCN clock is most readily influenced by arousal, but it is unclear if and how heterogeneity in the excitability
state of SCN neurons shapes their response to arousal signals, such as OXA. In whole-cell recordings we show that during the
day OXA recruits GABA-GABAA receptor signaling to suppress the RMP of hyperexcited silent as well as moderately hyperpolar-
ized AP-firing SCN neurons. In the AP-firing neurons, OXA hyperpolarized and silenced these SCN cells, while in the hyperex-
cited silent neurons OXA suppressed the RMP of these cells and evoked either AP-firing, depolarized low-amplitude membrane
oscillations, or continued silence at a reduced RMP. These results demonstrate how the resting state of SCN neurons determines
their response to OXA, and illustrate that the inhibitory action of this neurochemical correlate of arousal can trigger paradoxical
AP firing.
Introduction
Circadian and homeostatic signals interact to orchestrate the tempo-
ral architecture of behavioral and metabolic states (Bechtold & Lou-
don, 2013). The arousal-promoting orexin/hypocretin neurons in the
lateral hypothalamus and the circadian clock neurons within the
suprachiasmatic nuclei (SCN) are two circuits involved in this pro-
cess. In the SCN, activity of the circadian molecular clock, of which
the Period1 (Per1) gene forms a key component, is synchronized by
the environmental light-dark cycle through the glutamatergic retino-
hypothalamic tract. This drives daily changes in electrical states,
with SCN neurons being overtly more active (upstate) across the
day and less excited (downstate) at night (Brown & Piggins, 2007;
Colwell, 2011; Belle, 2015). Such pronounced day-night variation in
SCN electrical activity functions to communicate temporal signals to
the rest of the brain and body, including orexin neurons. Indeed, the
activity of orexin neurons is under circadian control (Zhang et al.,
2004), with their molecular activity (Estabrooke et al., 2001; Mar-
ston et al., 2008) and orexin release elevated during the behaviorally
active circadian night in nocturnal rodents (Deboer et al., 2004).
The phase of the SCN circadian clock is sensitive to feedback
from arousal-promoting stimuli, particularly during the day
(Mistlberger & Antle, 2011; Hughes & Piggins, 2012). Such stimuli
activate orexin neurons (Estabrooke et al., 2001; Marston et al.,
2008; Webb et al., 2008), whose brain-wide projection targets
include several structures of the neural circadian system (McGrana-
ghan & Piggins, 2001; Backberg et al., 2002). Indeed, orexin neu-
rons form putative synaptic appositions onto SCN clock neurons
and transcripts for orexin receptor 1 and 2 (OX1 and OX2, respec-
tively) are expressed in the SCN (Belle et al., 2014). Orexin exists
as two forms, orexin-A (OXA) and orexin-B, and exogenously
applied OXA acts to mainly suppress electrical activity of rodent
SCN cells (Brown et al., 2008; Klisch et al., 2009; Belle et al.,
2014). This suggests that OXA released in the vicinity of SCN neu-
rons during states of arousal can inﬂuence excitability in this brain
region.
The SCN neural population is both molecularly and neurochemi-
cally heterogeneous. For example, in mice in which an enhanced
green ﬂuorescent protein (EGFP) reports the activity of the Per1
promotor, many SCN neurons express the Per1-driven construct
(Per1-EGFP+ve), but in some neurons this construct is not detected
(EGFPve, presumed non-Per1 cells) (Kuhlman et al., 2000; Belle
et al., 2009). This heterogeneity also extends to the neurophysiology
of SCN neurons during the day, but not at night. Indeed, targeted
whole-cell recordings in mouse SCN revealed that although the
intrinsic membrane excitability states of Per1-EGFP+ve neurons and
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EGFPve cells are generally similar across much of the day-night
cycle, during the mid-afternoon (ZT6-10) they are vastly different
(Belle et al., 2009). During the mid-afternoon, Per1-EGFP+ve neu-
rons enter hyperexcited electrical states, where their resting mem-
brane potential (RMP) becomes severely depolarized (~ 33 mV)
and their input resistance (Rinput) elevates to maximal values (~ 2–
3 GO) (Belle et al., 2009). Consequently, at these hyperexcited
states Per1-EGFP+ve neurons stop generating action potentials
(APs) through depolarization blockade, and become completely
silent or generate depolarized low-amplitude membrane oscillations
(DLAMOs; Belle et al., 2009; Diekman et al., 2013). By stark con-
trast, EGFPve neurons do not enter hyperexcited states at any time
across the day-night cycle, and in the mid-afternoon they exhibit
lower Rinput (~ 1.5 GO) and rest at moderate RMP (~ 45 mV)
where they can readily discharge APs (Belle et al., 2009).
The physiological signiﬁcance for this dichotomy in Per1-
EGFP+ve and EGFPve excitability states during this time of the day
remains elusive, and here we explore the possibility that their resting
states shape and inﬂuence the way SCN neurons respond to inputs,
speciﬁcally the actions of the arousal-evoking neuropeptide, OXA.
Materials and methods
Animals
We used 28 male and female mice (8 weeks to 6 months old) hem-
izygous for the Period1::d2EGFP transgene (Per1-EGFP-expressing
mice in which an enhanced destabilized green ﬂuorescent protein
(EGFP) reports the activity of the Per1 promoter (a gift from Profes-
sor D. McMahon, Vanderbilt University, USA; see Kuhlman et al.,
2000). These animals were bred and supplied by the Biological Ser-
vices Facility of the University of Manchester, and were group-
housed on a 12 hour light : 12 hour dark (L : D) cycle (lights on at
07:00). Food and water were available ad libitum. All experimental
procedures were carried out according to the provisions of the UK
Animal (Scientiﬁc Procedures) Act 1986, and approved by the
Research Ethics Committee of the University of Manchester.
Preparation of living mouse SCN brain slices for in vitro
whole-cell recordings
Brain sections were prepared during the subjective day at Zeitgeber
Time (ZT) 1–2, with ZT0 deﬁned as the time of lights on. Coronal
brain slices containing the mid-level of the rostro-caudal SCN were
prepared from 28 male and female Per1-EGFP mice (one slice per
animal), as previously described (Belle et al., 2009, 2014). Brieﬂy,
animals were deeply anesthetized with isoﬂurane to minimize pain
and discomfort and killed by cervical dislocation and decapitation.
Brains were immediately removed and 250 lm thick coronal slices
cut with a vibroslicer (Campden Instruments, Loughborough, UK)
in an ice-cold (4 °C) low Na+/Ca2+, high Mg2+ sucrose-based artiﬁ-
cial cerebrospinal ﬂuid (aCSF) (in mM: NaCl 95; KCl 1.8; KH2PO4
1.2; CaCl2 0.5; MgSO4 7; NaHCO3 26; glucose 15; sucrose 50;
Phenol Red 0.005 mg/L; oxygenated with 95% O2; 5% CO2; pH
7.4, measured osmolarity 300–310 mOsmol/kg). For whole-cell
patch-clamp recordings, slices were transferred to a recording cham-
ber mounted on the stage of an upright Olympus epi-ﬂuorescence
microscope (BX51WI; Olympus, Japan), where they were continu-
ously perfused (~ 3 mL/min) with recording aCSF. The composition
of the recording aCSF was identical to the incubation solution
except for the following (mM): NaCl 127; CaCl2 2.4; MgSO4 1.3;
sucrose 0.
Whole-cell recordings
Targeted recordings (current- or voltage-clamp) were made from
Per1-EGFP positive (henceforth referred to as Per1-EGFP+ve)
neurons and cells in which EGFP could not be detected
(EGFPve), in the ventral and central sub-regions of the SCN on
the coronal plane. These SCN anatomical regions were chosen as
they are associated with arousal-promoting signal input to the
SCN (Morin, 2013). Per1-EGFP+ve neurons were visually identi-
ﬁed and distinguished from EGFPve cells with a 40 9 water
immersion UV objective (LUMplanFL/IR; Olympus) using epiﬂu-
orescence with a Leica camera (DFC 350 FX) and capturing soft-
ware (Leica Application Suite; Leica Microsystems, UK), as
previously described (Belle et al., 2009, 2014; Scott et al., 2010;
see also Fig. 1). Giga-ohm seal and cell membrane rupture were
done under infra-red video-enhanced differential interference con-
trast microscopy with an infra-red camera (Hitachi, Japan). An
Axoclamp 2A ampliﬁer (Molecular Devices, CA, USA) was used
for current-clamp recordings as previously described (Belle et al.,
2009, 2014). Patch pipette electrodes (7–10 MΩ) were fashioned
from thick-walled borosilicate glass capillaries (Harvard Appara-
tus) using a two-stage vertical micropipette puller (PB-10; Nara-
shige, Japan). Unless otherwise stated, electrodes were ﬁlled with
an internal solution containing (mM: K-gluconate 130; KCl 10;
MgCl2 2; K2-ATP 2; Na-GTP 0.5; Hepes 10, EGTA 0.5; pH
adjusted to 7.3 with KOH, measured osmolarity 295–
300 mOsmol/kg). Pipette series resistance (typically 10–30 MΩ)
was corrected using bridge-balance in current-clamp experiments
and was not compensated during voltage-clamp recordings. Cells
were accepted for analysis only if the series resistance was below
30 MΩ, remained within 20% of this value throughout the
recordings and the RMP remained stable for over 2 min before
orexin-A (OXA) application. RMP, spontaneous ﬁring rate (SFR)
and input resistance (Rinput) were determined within 1–2 min of
membrane rupture. The average ﬁring rate in ﬁring cells was
measured as the number of spikes per second within a 20 s win-
dow of stable ﬁring, and average RMP was measured as the
mean voltage (including AP or DLAMOs, for cells displaying
such activities) over a 20 s window using a custom-written
SPIKE2 script [Cambridge Electronic Design (CED), Cambridge,
UK]. Rinput was assessed only in current-clamp recordings and
was estimated by a series of hyperpolarizing current pulses (10
to 30 pA for 500 ms). Signals were sampled at 30 kHz, and
stored and analyzed on a personal computer using SPIKE2 software
(Version 7; CED). All data acquisition and step protocols were
generated through a micro 1401 mkII interface (CED).
Synaptic current measurement
Post-synaptic currents (PSCs) were measured with an Axopatch
200B ampliﬁer (Molecular Devices), holding the cells at 70 mV.
Patch pipettes (4–6 MΩ) were fashioned as described above and
ﬁlled with an internal solution that was identical to the one used
in current-clamp recordings, except for the following (mM): K-glu-
conate 120; KCl 20. Dialyzing SCN neurons with this concentra-
tion of Cl in the pipette causes inhibitory PSCs to reverse
between 40 to 50 mV (Itri & Colwell, 2003; Belle et al.,
2014). At 70 mV this positive shift in Cl reversal potential
causes GABA and glutamate PSCs to appear as inward currents.
To discriminate between excitatory and inhibitory PSCs, a cocktail
of antagonists (AP5 and CNQX) for the glutamate and/or GABAA
(Gabazine) receptors were used.
© 2016 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd.
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Drugs and analysis
Stock solutions (1000 9 concentration of working dilutions) for
orexin-A (OXA), D-2-amino-5-phosphonopentanoate (AP5), 6-cyano-
7-nitroquinoxaline-2,3-dione (CNQX) and gabazine (Tocris, Bristol,
UK) were made in puriﬁed MilliQ water. Working drug dilutions were
made in aCSF immediately before their application. Recording aCSF
(drug-free or containing drugs) solution was bath applied to SCN
slices by gravity-feed perfusion. Switching from drug-free to drug-
containing aCSF was done using an in-house built drug-switching
solenoid valves system. All recording and pharmacology methods
used for isolating and measuring the effects of OXA on synaptic activ-
ity, RMP and AP ﬁring frequency in SCN neurons were as previously
established (Belle et al., 2014). Analysis of PSC frequency and ampli-
tude were conducted ofﬂine by template-based sorting in CLAMPFIT
10.2 (Molecular Devices). Synaptic events were detected with an
amplitude threshold of 5 pA (see Belle et al., 2014).
Grouped data from Per1-EGFP+ve and EGFPve neurons were
initially examined for normality using the Kolmogorov–Smirnov
(K–S) test. When normality was found, data were statistically
Fig. 1. Whole-cell targeting of Per1-EGFP+ve and EGFP-ve neurons in a living SCN slice. (A) Recording setup showing bright-ﬁeld image (4 9) of a living
coronal SCN slice (250 lm thick) taken at the mid-rostro-caudal level. (B) Image of Per1-EGFP+ve ﬂuorescence signal (20 9) taken from the slice shown in
(A) with a FITC (488 nm, optimum for EGFP) ﬁlter. Insets C1 and C2 are representative photomicrographs showing patch pipette targeting of EGFPve (C1,
follow vertically) or Per1-EGFP+ve (C2) neurons (40 9) in the slice shown in A and B. Insets rows show bright-ﬁeld, ﬂuorescence (FITC), and merged bright-
ﬁeld and ﬂuorescence images. (D and E) Spontaneous membrane excitability states of Per1-EGFP+ve (D) and EGFPve (E) SCN neurons over the day. (D)
Example of typical current-clamp traces from Per1-EGFP+ve SCN neurons recorded in the morning (ZT2–5) and afternoon (ZT6–10). Note that Per1-EGFP+ve
neurons recorded in the morning are at moderate resting membrane potential (RMP: ~ 45 mV) and discharging action potentials (APs), while in the afternoon
they become hyperexcited with RMPs of 25 to 35 mV and unable to generate APs. These cells are either silent or generating depolarized low-amplitude
membrane oscillations (DLAMOs). By contrast, EGFPve neurons (E) remain at moderate RMP throughout the day, ﬁring APs. Dashed lines in C indicate the
outline of the patch pipette. SCN, suprachiasmatic nuclei; OX, optic chiasm; P, patch pipette. [Colour ﬁgure can be viewed at wileyonlinelibrary.com].
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compared using two-way ANOVA with repeated measures and/or
paired/unpaired two-tailed t tests. Bonferroni correction was used
for multiple comparisons. In the absence of normality, statistical
comparisons were made using the Mann–Whitney U Test or
related samples Wilcoxon Test (SPSS version 22; SPSS Inc., Chi-
cago, IL, USA). For all tests, P < 0.05 was considered signiﬁcant.
All numerical data both in text and graphs represent
mean  SEM.
Results
Mid-afternoon Per1-EGFP+ve and EGFPve neurons differ in
their excitability states
We used epiﬂuorescence and during the afternoon (ZT6-10) made
targeted whole-cell current-clamp recordings from identiﬁed Per1-
EGFP+ve and EGFPve neurons (n = 21 neurons each, from 14
animals) in the ventral and central SCN sub-regions to determine if
and how their intrinsic excitability states contributed to their
response to OXA (see Materials and methods and Fig. 1). Using this
approach we conﬁrmed previous results (Belle et al., 2009) that dur-
ing the mid-afternoon Per1-EGFP+ve neurons enter hyperexcited
electrical states (Fig. 1D) with RMP and Rinput values (RMP =
30.5  0.8 mV; Rinput = 2.4  0.1 GΩ) that are signiﬁcantly
higher than those measured in EGFPve cells (RMP =
45  1 mV; T(40) = 11.393, P < 0.0001; Rinput = 1.4  0.05
GΩ : Z = 5.472, P < 0.0001). As Per1-EGFP+ve neurons in these
electrical states cannot discharge APs, while EGFPve cells can,
comparison of SFR revealed a signiﬁcant difference, with elevated
SFR values in EGFPve neurons (Fig. 1E) and no spiking activity
in the severely depolarized Per1-EGFP+ve cells (Per1-
EGFP+ve = 0 Hz; EGFPve = 4  0.4 Hz; Z = 5.946,
P < 0.0001: Fig. 1D).
OXA suppresses the RMP of Per1-EGFP+ve and EGFPve
neurons
During the day, OXA acts in the SCN to mainly suppress excitabil-
ity in Per1-EGFP+ve neurons by elevating the pre-synaptic release
of GABA onto post-synaptic GABAA receptors (Belle et al., 2014).
To test if a similar mechanism of OXA suppression operates in
EGFPve cells and to investigate whether the contrasting electrical
states in mid-afternoon Per1-EGFP+ve and EGFPve neurons func-
tionally determine their responses to OXA, we bath applied OXA
(80 nM for 3 min) to the current-clamped Per1-EGFP+ve and
EGFPve neurons, and compared if and how their electrical states
changed in the presence of this neuropeptide.
The majority of Per1-EGFP+ve (16/21; ~ 76%) and EGFPve
(16/21; ~ 76%) neurons tested responded to OXA, with a ≥ 2 mV
change in their RMP. Within these OXA-sensitive cells, most (15/
16; ~ 94%) of EGFPve neurons responded by signiﬁcant hyperpo-
larization of their RMP when compared with baseline values
(T(14) = 7.931, P < 0.0001; Fig. 2A and H), and only one cell
showed membrane depolarization (data not shown). The hyperex-
cited Per1-EGFP+ve neurons (16/16) also responded to OXA by
suppressing their RMP to levels that were signiﬁcantly different
from baseline (T(15) = 14.626, P < 0.0001; Fig. 2C–E and H). By
comparison, application of OXA in the presence of the selective
OXA receptor antagonist, SB334867 (10 lM), prevented all these
cells from changing their RMP (data not shown), replicating our
previous observation (Belle et al., 2014). Subsequent two-way
repeated measures ANOVA comparison revealed a signiﬁcant main
effect of cell-type (F1, 29 = 39.793, P < 0.0001), treatment
(F1, 29 = 267.252, P < 0.0001) and cell-type 9 treatment interaction
(F1,29 = 71.149, P < 0.0001) in RMP. Comparisons of RMPs
between these two OXA-responsive cell-types showed that, as in the
overall cell populations, Per1-EGFP+ve neurons rested at a signiﬁ-
cantly more depolarized level than EGFPve cells (30.5  1 vs.
45.5  1.3 mV; T(29) = 9.423, P < 0.0001). The RMPs attained
by Per1-EGFP+ve and EGFPve cells during their maximal steady-
state OXA response were also signiﬁcantly different (44.6  1.3
vs. 50  1.3 mV; T(29) = 2.950, P = 0.006; Fig. 2H). When delta
RMP between the two cell populations was compared, the magni-
tude of OXA-evoked hyperpolarization in Per1-EGFP+ve neurons
(n = 16; 14.2  1 mV) was signiﬁcantly larger (T(29) = 8.435,
P < 0.0001) than those measured in EGFPve cells (n = 15;
4.5  0.6 mV; Fig. 2I).
Cell-state and cell-type determine the response magnitude of
SCN neurons to OXA
The above observation suggests that afternoon cell-state and/or cell-
type underpins the contrasting magnitude in response to OXA. To
directly investigate these possibilities we next assessed the magni-
tude of OXA-evoked membrane suppression in Per1-EGFP+ve cells
current-clamped in the morning (ZT2-5), a time when the natural
intrinsic excitability state of Per1-EGFP+ve neurons is moderate
and similar to that measured in EGFPve cells (Fig. 1D, compare
with 1E), and importantly, is vastly different from afternoon Per1-
EGFP+ve cells (Fig. 1D, see also Belle et al., 2009). We compared
the magnitude of these morning responses to OXA with those
measured in afternoon neurons. As previously described, morning
Per1-EGFP+ve neurons rested at moderate RMPs (44.6  1.5 vs.
afternoon 30.5  1 mV; T(26) = 8.301, P < 0.0001) and can
Fig. 2. Orexin (OXA) indirectly suppresses the activity of Per1-EGFP+ve and EGFPve SCN neurons. (A) Typical inhibitory response of an SCN EGFPve
neuron to bath application of OXA during the mid-afternoon, causing membrane hyperpolarization and complete suppression of AP ﬁring. (B–E) Whole-cell
recordings showing suppressive response of moderately hyperpolarized/excited morning (B) and hyperexcited afternoon (C–E) Per1-EGFP+ve neurons to bath
applied OXA. In morning cells, OXA caused membrane hyperpolarization and suppression of AP ﬁring. In some afternoon cells the OXA-evoked RMP sup-
pression triggered paradoxical ﬁring of APs (E, 7/16 responsive cells; see L), while in others it elicits DLAMOs activity (D, 4/16 responsive cells). In the
remaining OXA responsive neurons (5/16) RMP hyperpolarization did not evoke APs or DLAMOs and the cells remained silent (C). (F–G) Consecutive traces
from cells (A) and (C), respectively, showing examples that co-treatment of cells suppressed by OXA (e.g. A–C) with OXA and the selective GABAA receptor
antagonist, gabazine, abolished OXA effects. (H–L) Summary analyses of OXA’s effects on excitability of Per1-EGFP+ve and EGFPve neurons, with (H)
showing suppression of RMP, which in both populations was signiﬁcantly different from baseline (12 morning and 16 afternoon Per1-EGFP+ve, and 15
EGFPve cells). (I) The magnitude of this OXA-evoked change (D) in RMP was signiﬁcantly different when cell-type and cell-state were compared; hyperex-
cited afternoon Per1-EGFP+ve > moderately resting morning Per1-EGFP+ve > EGFPve neurons. Co-application of gabazine with OXA prevented D in RMP
in all cells tested (n = 5 Per1-EGFP+ve and 5 EGFPve cells; single degree of freedom t-test; P > 0.05). (J–K) In EGFPve and morning Per1-EGFP+ve neu-
rons OXA-evoked hyperpolarization signiﬁcantly suppressed ﬁring activity. (L) Quantiﬁcation of the paradoxically-elicited spiking activity in Per1-EGFP+ve
cells during OXA-evoked hyperpolarization. ***P < 0.0001; **P < 0.01; *P < 0.05. Data shown in panels H to L are plotted as mean  SEM, with data
points from individual neurons depicted as ﬁlled black circles. [Colour ﬁgure can be viewed at wileyonlinelibrary.com].
© 2016 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd.
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discharge APs (2.5  0.4 vs. 0 Hz; Z = 3.594, P < 0.0001;
Fig. 1D, 17 neurons from six animals). When challenged with
OXA, the majority of these cells (12/17; 71%) reduced excitability
by hyperpolarization and suppression or abolishment of AP ﬁring
(44.6  1.5 vs. 53.4  1.7 mV, T(11) = 8.380, P < 0.0001;
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H and K), while 2/17 (~ 12%) did not respond and 3/17 (~ 17%)
showed membrane excitation (data not shown). When the magnitude
of this RMP change was compared with that measured in hyperex-
cited afternoon Per1-EGFP+ve neurons, a signiﬁcant difference was
detected (8.9  1.1 vs. 14.2  1 mV; T(26) = 3.654, P = 0.001),
indicating that OXA evoked larger delta RMP in afternoon than in
morning Per1-EGFP+ve cells (Fig. 2I). We next compared OXA-
evoked delta RMP measured in morning Per1-EGFP+ve with that
assessed in EGFPve cells to test whether elements of cell-type
with similar excitability state also determine the magnitude of OXA
response. Interestingly, although the steady-state RMP attained dur-
ing OXA application was not signiﬁcantly different in these two cell
populations (53.4  1.7 vs. 50  1.3 mV; P > 0.05; Fig. 2H),
delta RMP in Per1-EGFP+ve neurons was signiﬁcantly larger than
that measured in EGFPve cells (8.9  1.1 vs. 4.5  0.6 mV;
T(25) = 3.822, P = 0.001; Fig. 2I). It is noteworthy, however, that
when the magnitude of the T-values and mean difference between
the deltas were considered across time of day (morning vs. after-
noon) as well as neuronal type (Per1-EGFP+ve vs. EGFPve), cell-
state rather than cell-type emerged as the more deﬁning determinant
of delta RMP magnitude to OXA (DRMP in afternoon Per1-
EGFP+ve > morning Per1-EGFP+ve > EGFPve; Fig. 2I).
OXA-evoked suppression of RMP elicits distinct membrane
excitability activities in afternoon Per1-EGFP+ve and
EGFPve neurons
Intriguingly, OXA-evoked hyperpolarization produced diverse
changes in afternoon Per1-EGFP+ve membrane excitability that
were distinct from those seen in EGFPve cells (n = 16 and 16
cells, respectively, from 14 animals). In EGFPve neurons, OXA-
evoked membrane hyperpolarization caused signiﬁcant suppression
or abolishment of AP generation (3.7  0.5 Hz vs.
0.07  0.07 Hz; Z = 3.431, P = 0.001; Fig. 2A and J), effects
that were comparable to those elicited in morning Per1-EGFP+ve
neurons (see above). By comparison, membrane hyperpolarization
by OXA in afternoon Per1-EGFP+ve neurons produced three dis-
tinct excitability activities. In some of these severely depolarized
silent cells (5/16; ~ 31%), the membrane hyperpolarized but the
cells remained silent (Fig. 2C). In others (4/16; 25%), OXA-evoked
RMP suppression caused these cells to generate DLAMOs
(Fig. 2D). Unexpectedly, in the remaining cells (7/16; ~ 44%), sup-
pression of RMP by OXA paradoxically triggered spiking activity
(2.1  0.3 Hz; Fig. 2E and L), presumably by transiting these cells
from depolarization blockade (~ 25 to 36 mV) to values of
RMP (~ 45 mV) at which they can generate APs. This paradoxi-
cal increase in ﬁring frequency during OXA-evoked hyperpolariza-
tion was signiﬁcant when compared with their initial baseline silent
state (Z = 2.414, P = 0.016; Fig. 2L).
The trigger for the range of excitability activities seen in after-
noon Per1-EGFP+ve neurons by OXA could be simply by the relief
of these cells from depolarization blockade through suppressive
GABA-GABAA signaling. We therefore tested whether such a com-
mon and general mechanism of OXA-dependent rescue of hyperex-
cited Per1-EGFP+ve neurons from depolarization blockade accounts
for the array of electrical behaviors seen during their responses to
OXA. To do this, we recorded from afternoon Per1-EGFP+ve neu-
rons and mimicked the hyperpolarizing effects of OXA by applying
controlled steady-state negative currents which artiﬁcially hyperpo-
larized and maintained their RMPs at appropriate levels (from 25
to ~ 35 and 45 mV; Fig. 3). From the 10 cells actively manipu-
lated in this way, 7/10 (70%, from three animals) ﬁred APs when
maintained at ~ 45 mV (Fig. 3A, B and D). Of these seven cells,
3 (43%) produced DLAMOs when membrane potential was main-
tained at ~ 33 mV (Fig. 3A); observations that support our previ-
ous ﬁnding (Belle et al., 2009). The remaining cells (3/10; 30%)
hyperpolarized but sustained silence throughout steady-state current
injection (from 25 to 45 mV; Fig. 3C). Passage of a square
depolarizing pulse during manual suppression produced APs in these
neurons (Fig. 3C). This suggests that intrinsic mechanisms operate
to maintain membrane silence in these cells even in the potential
range at which APs could be spontaneously ﬁred, as shown by the
acute excitatory stimulation. Indeed, this observation supports previ-
ous ﬁndings that single SCN neurons do not necessarily discharge
APs, even when at values of RMP that are permissive of AP ﬁring
(M. D. C. Belle and H. D. Piggins, unpublished observations and
see also (Rohling et al., 2006)). Furthermore, in these hyperexcited
cells a rebound spike can be triggered if the RMP is acutely
removed from depolarization blockade by a brief hyperpolarizing
pulse (Fig. 3E and F). By contrast, manual steady-state hyperpolar-
ization of morning Per1-EGFP+ve and afternoon EGFPve cells
invariantly ceased AP generation (data not shown).
OXA-evoked increase in spontaneous post-synaptic current
amplitude is significantly larger in afternoon Per1-EGFP+ve
neurons than in EGFP-ve cells
When OXA-responsive Per1-EGFP+ve (n = 5) and EGFPve
(n = 5) neurons were re-tested with OXA in the presence of the
selective GABAA receptor blocker, gabazine, no effects on RMP
were observed (Fig. 2F, G, and I). This replicates our earlier ﬁnding
that gabazine blocks RMP effects of OXA on Per1-EGFP+ve neu-
rons during the day (Belle et al., 2014), and extends this to show
that gabazine also prevents hyperpolarizing actions of OXA in
EGFPve cells. This indicates that in both cell types, OXA recruits
indirect/pre-synaptic GABA to signal via the GABAA receptor and
hyperpolarize SCN neurons during the day. Our afternoon current-
clamp data also demonstrates that the magnitude of RMP suppres-
sion by this pre-synaptic action of OXA is signiﬁcantly larger in
hyperexcited Per1-EGFP+ve neurons than in moderately resting
EGFPve cells (Fig. 2I). This suggests that Per1-EGFP+ve and
EGFPve SCN neurons have differential response characteristics to
OXA-evoked synaptic GABA-GABAA receptor signaling. To inves-
tigate this, we next performed voltage-clamp recordings in SCN
Per1-EGFP+ve and EGFPve neurons (n = 7 cells each, from ﬁve
animals) and compared the effects of bath-applied OXA on the fre-
quency and amplitude of PSCs. To isolate GABAergic events, we
performed these recordings in the presence of AP5 and CNQX,
respective blockers of NMDA and non-NMDA receptors.
Our results indicate that OXA signiﬁcantly increased the
GABAergic PSC frequency (Per1-EGFP+ve baseline = 4.1 
0.5 Hz; OXA = 9  0.9 Hz, T(6) = 5.158, P = 0.002; and
EGFPve baseline = 2.3  0.6 Hz; OXA = 4.7  0.7 Hz, T(6) =
3.829, P = 0.009) and amplitude (Per1-EGFP+ve baseline =
14.2  1.8 pA; OXA = 26.1  1.2 pA, T(6) = 7.437, P <
0.0001; and EGFPve baseline = 17.5  3.2 pA; OXA = 23.6 
3.2 pA, T(6) = 4.043, P = 0.007) in ~ 90% of recorded cells
(Fig. 4A and C). When comparisons of PSC amplitude and fre-
quency were performed across cell-types, two-way repeated mea-
sures ANOVA revealed a signiﬁcant main effect of cell-type
(F1,12 = 17.787, P = 0.001) and treatment (F1,12 = 41.202, P <
0.0001), but no cell-type 9 treatment interaction (F1,12 = 4.400,
P = 0.058) for frequency. For amplitude, no main effect of cell-type
was seen (F1,12 = 0.016, P = 0.902), but signiﬁcance in main effect
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of treatment (F1,12 = 67.156, P < 0.0001) and cell-type 9 treatment
interaction (F1,12 = 7.155, P = 0.02) were found. Subsequent com-
parisons of delta amplitude and frequency revealed that the OXA-
evoked change in PSC amplitude was signiﬁcantly different in these
two cell-types (T(12) = 2.659, P = 0.021), with larger PSC measured
in Per1-EGFP+ve neurons than in EGFPve cells (11.9  1.6 vs.
6 1.5 pA; Fig. 4C). Contrary with this, no difference was seen in
OXA-evoked delta frequency in these two cell populations, although
this difference approached signiﬁcance (4.8  1 Hz vs.
2.4  0.6 Hz; T(12) = 2.109, P = 0.057). In all recordings, the
OXA-sensitive synaptic events were completely abolished by bath
applied gabazine (Fig. 4B), indicating that they were indeed
GABAA receptor mediated.
Discussion
An important quest in neuroscience is identifying processes that
shape how neurons respond to inputs. Here, we show that molecular
clock-driven changes in membrane potential and neural state is a
key factor in shaping SCN neuronal responses to a neurochemical
correlate of arousal. Speciﬁcally, we revealed that the intrinsic
excitability state of Per1-EGFP+ve and EGFPve neurons during
the day determines how these cells respond to OXA.
Our results indicate that the vast majority of moderately hyperpo-
larized AP-discharging EGFPve (~ 94%) and Per1-EGFP+ve
(~ 71%) cells were hyperpolarized and silenced by OXA. This dif-
fers from hyperexcited Per1-EGFP+ve neurons in which diverse
electrical activities were seen during OXA-evoked RMP suppres-
sion, ranging from DLAMO generation to paradoxical spiking. In
both cell populations these OXA-dependent electrical behaviors
relied on GABA-GABAA receptor signaling, but not ionotropic glu-
tamatergic transmission. This is consistent with our previous obser-
vation that OXA-mediated pre-synaptic release of GABA in the
SCN is critical for OXA’s modulatory suppression of SCN neuron
activity during the day (Belle et al., 2014). Here, we extend these
observations to show that this OXA-GABA-GABAA receptor-
Fig. 3. Manual hyperpolarization elicits a range of electrical states in hyperexcited Per1-EGFP+ve neurons that are comparable to those evoked by OXA. (A)
Typical silent Per1-EGFP+ve neuron ﬁring APs when manually maintained at ~ 44 mV and producing DLAMOs when transiting between silent and ﬁring states
(equivalent to OXA-evoked responses in Fig. 2E). Gradual release from forced hyperpolarization returned this cell to DLAMO and silent states. (B) A DLAMOs
producing neuron forced to ﬁre APs upon manual hyperpolarization and stopped/reduced AP ﬁring when RMP is maintained at a more negative potential. Cell dis-
charges APs when RMP is returned to ﬁring range. (C) Typical silent Per1-EGFP+ve neuron that sustained silence when hyperpolarized to a RMP that promotes
AP discharge (equivalent to OXA-evoked response shown in 2C). Depolarizing pulses of 10 and 20 pA elicited AP ﬁring, demonstrating this cell’s ability to pro-
duce an AP when acutely excited. (D) Silent hyperexcited Per1-EGFP+ve neuron producing APs when maintained at the ﬁring range (~ 45 mV) but in between
was rendered silent by RMP maintenance below (58 mV) ﬁring threshold. (E and F) Typical rebound spike response in depolarized silent cell by a hyperpolariz-
ing pulse which transiently removes the cell from depolarization blockade, re-activating an AP. [Colour ﬁgure can be viewed at wileyonlinelibrary.com].
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mediated action also operates to suppress activity in EGFPve neu-
rons, eliciting distinct and diverse electrical behaviors in these iden-
tiﬁed SCN cell populations. Our present results also demonstrate
that the magnitude of these OXA actions depends primarily on the
intrinsic membrane potential of the neurons.
During the day, the phase of the SCN clock can be reset by so-
called non-photic/arousal-promoting stimuli (Mistlberger & Antle,
2011; Hughes & Piggins, 2012). This non-photic resetting is associ-
ated with suppression of SCN cellular activity and clock gene
expression (Maywood et al., 2002; Hamada et al., 2004). One of
the main brain structures that communicates non-photic information
to SCN neurons is the thalamic intergeniculate leaﬂet (IGL) which
directly innervates the SCN through the geniculohypothalamic tract
(GHT; Harrington, 1997; Golombek & Rosenstein, 2010). An
important neurochemical of the IGL-GHT pathway is neuropeptide-
Y (NPY; reviewed in Yannielli & Harrington, 2004). Indeed, during
the day, NPY inhibits SCN electrical activity (including Per1-EGFP
cells), suppresses Per1 expression, and phase-advances the SCN
clock (Liou & Albers, 1991; Medanic & Gillette, 1993; Shibata &
Moore, 1993; Huhman & Albers, 1994; van den Pol et al., 1996;
Cutler et al., 1998; Fukuhara et al., 2001; Maywood et al., 2002;
Besing et al., 2012; Belle et al., 2014).
Surprisingly, the suppressive action of OXA on SCN electrical
activity during the day does not have such dramatic effects on clock
phase, but instead accentuates the actions of NPY to potently inhibit
cellular activity and phase-shift the SCN clock (Belle et al., 2014).
These selective effects of OXA may be important in that, when act-
ing alone, it relieves SCN-inhibition of behavioral activity without
affecting overall circadian rhythmicity. This allows animals to
respond to acute behavioral necessities, such as grooming and drink-
ing (van Oosterhout et al., 2012), without uncoupling behavioral
rhythms from prevailing light-dark cycles. Under circumstances
when non-photic adjustment of the clock phase may be necessary,
such as during physiological conditions that promote IGL-SCN sig-
naling, OXA acts to reinforce these non-photic signals to the SCN.
This implicates OXA signaling in the integration of non-photic
communication in the SCN, and its distinct and diverse effects on
the electrical activity of Per1-EGFP+ve and EGFPve neurons seen
here may partially underpin such capacity and plasticity in its
action.
At multiple brain sites OXA acts to cause excitation, but the
importance of its engagement with local GABAergic circuits to sup-
press/modulate spiking activity in cells is becoming more prominent.
For example, in the lateral hypothalamus where orexinergic and
melanin-concentrating hormone (MCH) neurons are intermingled,
OXA acts through local GABAergic interneurons to mainly suppress
electrical activity of MCH cells. This provides a possible switching
mechanism which appropriately isolates the conﬂicting signals of
sleep and wakefulness (Apergis-Schoute et al., 2015). Here, and in
our previous work, we provide evidence that this local ‘switch con-
trol’ also operates in the SCN circuit, which presumably acts in
behaving animals to avoid conﬂicts between circadian and arousal
signals (Belle et al., 2014). Indeed, our present data provide some
insight into the complex nature of such ‘switch control’, indicating
that investigation of how this is achieved in vivo to govern behavior
will be a challenging venture.
Our results indicate that the change in GABAergic PSC amplitude
elicited by OXA in Per1-EGFP+ve neurons was signiﬁcantly larger
than those measured in EGFPve cells. This likely underpins the
signiﬁcantly greater magnitude of OXA-evoked RMP suppression in
Per1-EGFP+ve neurons than in EGFPve cells. As the delta PSC
frequency evoked by OXA between these cell types approached but
was not statistically signiﬁcant, the results suggest the existence of
mainly clock-driven post-synaptic membrane properties/processes
that render Per1-EGFP+ve neurons more amenable to OXA-depen-
dent GABA-GABAA receptor signaling than EGFPve cells.
Indeed, even when comparison was made between cell-types of sim-
ilar moderate RMPs and ﬁring capability (morning Per1-EGFP+ve
vs. EGFPve cells), OXA-induced delta RMP was unexpectedly
larger in Per1-EGFP+ve neurons than in EGFPve cells. Several
intrinsic post-synaptic membrane properties of neurons are associ-
ated with synaptic processing gain, measured as PSC amplitude and
Fig. 4. Orexin (OXA) increases the frequency and amplitude of post-synaptic currents (PSC) in Per1-EGFP+ve and EGFPve neurons. (A) Example of traces
from a Per1-EGFP+ve neuron (voltage-clamped at 70 mV) with the top and bottom traces showing PSC frequency in baseline (top) and during OXA (bot-
tom) bath application. This recording was made in the presence of the speciﬁc glutamatergic receptor antagonists (AP5 and CNQX, NMDA/AMPA/kainate-
types) in the bath, which did not prevent the OXA-evoked increase in PSC frequency and amplitude. However, these OXA-evoked events were completely
abolished in the presence of the speciﬁc GABAA receptor blocker, gabazine (B). (C) Summary of OXA-dependent delta increase in PSC frequency and ampli-
tude in Per1-EGFP+ve and EGFPve neurons, showing signiﬁcant differences between cell-type in PSC amplitude, but not frequency (NS). *P < 0.05. Analy-
sis was performed on recordings from 7 Per1-EGFP+ve and 7 EGFPve neurons. Data shown in panel C are plotted as mean  SEM, with data points from
individual neurons depicted as ﬁlled black circles. [Colour ﬁgure can be viewed at wileyonlinelibrary.com].
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summation. In the entorhinal stellate cells, for example, depolariza-
tion and increases in input resistance give rise to a voltage-depen-
dent increase in excitatory and inhibitory post-synaptic potential
amplitude (Economo et al., 2014). In a similar fashion, alteration in
input resistance can regulate synaptic transmission efﬁcacy at single
synapses (see Harnett et al., 2012 for example). Increased post-
synaptic receptor density also inﬂuences the magnitude of synaptic
signaling, by primarily augmenting the PSC amplitude elicited by
pre-synaptic neurotransmitter release, a process that occurs at central
GABAergic synapses (Nusser et al., 1998). Although the density of
post-synaptic GABAA receptor expression in Per1-EGFP+ve and
EGFPve neurons is unknown, measurement of membrane proper-
ties in these cells revealed that during the day the Rinput and RMP
of Per1-EGFP+ve neurons are signiﬁcantly higher than those mea-
sured in EGFPve cells (see also Belle et al., 2009). This differ-
ence in excitability states can therefore account for the distinctive
response magnitude to OXA measured in these two cell populations.
Perhaps less surprising is the observation that OXA-induced delta
RMP in morning Per1-EGFP+ve neurons is smaller than that eli-
cited by this neuropeptide in afternoon Per1-EGFP+ve cells. Indeed,
as is the case for morning Per1-EGFP+ve and EGFPve neurons,
on average the intrinsic baseline Rinput value of Per1-EGFP+ve cells
is signiﬁcantly elevated in the afternoon when compared with morn-
ing measurements (Belle et al., 2009). This positive association of
response magnitude with Rinput further reinforces the possibility that
post-synaptic membrane resistance of SCN neurons largely con-
tributes to cell-state and, to a lesser extent, cell-type response mag-
nitude to OXA. By extension this post-synaptic property may also
inﬂuence the way SCN neurons respond to other neurochemical sig-
nals conveyed to this brain structure.
More broadly, our study reveals how intrinsic electrical states
can shape neural responses to incoming signals. Hyperexcited and
moderately resting neurons with high input resistance are reported
in a number of other brain regions, such as the cerebellum, habe-
nula and arcuate nuclei of the mediobasal hypothalamus (Belousov
& van den Pol, 1997; Raman et al., 2000; Pugh & Raman, 2009;
Sakhi et al., 2014a,b). As these regions also express circadian clock
genes, it is plausible that circadian-driven neural states determine
how input signals, such as those associated with appetite and motor
co-ordination, are received and processed in these brain tissues.
Although the function of hyperexcited neurons is yet to be deter-
mined, it is likely that, as in the SCN, inhibitory signals conveyed
to these brain regions may cause paradoxical generation of spiking
activity. Indeed, our manual RMP manipulation in hyperexcited
SCN Per1-EGFP+ve cells with steady-state current injection was
able to mimic and recapitulate all of the electrical behaviors elicited
by OXA in these afternoon SCN neurons. This demonstrates that
by the simple removal of hyperexcitation or depolarization block-
ade, DLAMOs and normal spiking can be resumed in some of
these cells. This argues for a general mechanism through which
inhibitory signals, such as OXA acting through GABA, can evoke
diverse and complex electrical activities in SCN neurons. Such neu-
ronal state transition by inhibitory signals, as evoked here in the
SCN by OXA, likely act to shape how cells respond and process
information to subsequent synaptic inputs. For example, the transi-
tion from depolarization blockade to spiking would enable cells to
be more responsive to subsequent excitatory signals.
The distinct responses to OXA in Per1-EGFP+ve and EGFPve
cells may therefore be central to the way SCN neurons organize,
integrate and appropriately balance incoming excitatory photic vs.
suppressive arousal signals in behaving animals across the day.
Indeed, photic and non-photic signals can interact with each other at
the level of the SCN; the effects of non-photic resetting cues are
cancelled if the non-photic signal is followed by a light pulse, or
administration of glutamatergic receptor agonists (Biello & Mro-
sovsky, 1995; Biello et al., 1997; Gamble et al., 2004). This may
permit animals to appropriately respond to potentially competing
external and internal signals in order to organize physiology and
behavior.
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